Ethnicity-based differences in breast cancer features and responsiveness to CDK4/6 inhibitors combined with endocrine therapy - Authors' reply.

Gao, Jennifer J; Cheng, Joyce; Beaver, Julia A; Prowell, Tatiana M

Gao, Jennifer J; Cheng, Joyce; Beaver, Julia A; Prowell, Tatiana M.

Afiliação

Gao JJ; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: jennifer.gao@fda.hhs.gov.
Cheng J; Office of Translational Sciences, Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
Beaver JA; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD 20993, USA.
Prowell TM; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD 20993, USA.

Lancet Oncol ; 21(3): e131, 2020 03.

Article em En | MEDLINE | ID: mdl-32135115

Assuntos

Quinase 6 Dependente de Ciclina; Etnicidade; Quinase 4 Dependente de Ciclina; Humanos; Estados Unidos; United States Food and Drug Administration

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Etnicidade / Quinase 6 Dependente de Ciclina Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google